The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:2019-a-2020, November 2006
doi: 10.1176/appi.ajp.163.11.2019-a
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by MATTES, J. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by MATTES, J. A.
Related Collections
* General Topics in Psychiatry

Letter to the Editor

Antabuse Reaction With Ceftin

JEFFREY A. MATTES, M.D.
Princeton, N.J.

To the Editor: The antibiotic Ceftin is cefuroxime axetil (1); the axetil is converted to acetaldehyde (1). I recently encountered the following disulfiram reaction.

A patient receiving Antabuse (disulfiram) (125 mg in the morning for the prior 18 months) with generally good compliance was given Ceftin (cefuroxime) and, within 1 hour after the first oral dose (250 mg at 6 p.m.), developed nausea, vomiting, and stomach cramps. These symptoms lasted 8 to 9 hours; the patient did not take another dose of the Ceftin (he was not rechallenged).

This reaction was presumably caused by the accumulation of acetaldehyde (alcohol is converted to acetaldehyde; disulfiram blocks the conversion of acetaldehyde to acetate, and a disulfiram reaction is caused by increased acetaldehyde levels). Odyssey Pharmaceuticals (makers of Antabuse) had no reports of an interaction between Ceftin and Antabuse, but very small amounts of alcohol can cause a disulfiram reaction, so it might be assumed that even smaller amounts of acetaldehyde can do the same.

Footnotes

Reprints are not available; however, Letters to the Editor can be downloaded at http://ajp.psychiatryonline.org.

Reference

  1. Manufacturer’s approved labeling for Ceftin, in Physicians’ Desk Reference. Montvale, NJ, Thomson PDR, 2006, pp 1369-1373




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by MATTES, J. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by MATTES, J. A.
Related Collections
* General Topics in Psychiatry


Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org